As with any other selective COX-2 inhibitors selectively inhibits etoricoxib isoform 2 of cyclo-oxigenase enzyme (COX-2). This reduces the generation of prostaglandins (PG's) from arachidonic acid. Among the various functions attached PGs, their role in the inflammation cascade should be. Selective COX-2 inhibitors (aka COXIB ") shows marked by type of activity is less than 1 cycloxigenase compared with traditional non-steroidal anti-inflammatory drugs (NSAIDs). This led to a decline in activity is the cause of reducing the toxicity of the gastro-intestinal tract, as in several large clinical studies with different COXIB (see below links to NEJM and The Lancet).
Several clinical studies and meta-analysis showed that treatment with COXIB led to an increase in adverse cardiovascular events compared to placebo. From these results, some molecules from the trade (rofecoxib, in September 2004 and valdecoxib, in April 2005). In addition, FDA and the EMEA (European Community and U.S. health authorities, respectively) began the process of reviewing an entire class, so that NSAIDs and COX-2 inhibitors.
What is the shelf life of the pills?
- The expiry date is mentioned on each blister. It is different for different batches. The shelf life is 2 years from the date of manufacture and would differ from batch to batch depending on when they were manufactured.





